Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles

被引:0
|
作者
Tomohiro Terada
Daiki Hira
机构
[1] Shiga University of Medical Science Hospital,Department of Pharmacy
来源
关键词
Drug transporters; Pharmacokinetics; Polymorphisms; Drug–drug interaction;
D O I
暂无
中图分类号
学科分类号
摘要
The efficacy and safety of pharmacotherapies are determined by the complex processes involved in the interactions between drugs with the human body, including pharmacokinetic aspects. Among pharmacokinetic factors, it has been recognized that drug transporters play critical roles for absorption, distribution and excretion of drugs, regulating the membrane transport of drugs. The vast amounts of information on drug transporters collected in the past 20 years have been organized according to biochemical, molecular, genetic, and clinical analyses. Novel technologies, public databases, and regulatory guidelines have advanced the use of such information in drug development and clinical practice. In this review, we selected some clinically important drug transporters expressed in the intestine and liver, and introduced the research history and current knowledge of their pharmacokinetic, pathophysiological, and pharmacogenetic implications.
引用
收藏
页码:508 / 519
页数:11
相关论文
共 50 条
  • [41] Pharmacogenomics of Tamoxifen: Roles of Drug Metabolizing Enzymes and Transporters
    Kiyotani, Kazuma
    Mushiroda, Taisei
    Nakamura, Yusuke
    Zembutsu, Hitoshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (01) : 122 - 131
  • [42] Organic cation transporters and their roles in antiretroviral drug disposition
    Jung, Norma
    Taubert, Dirk
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (07) : 773 - 787
  • [43] Peptide transporters and their roles in physiological processes and drug disposition
    Rubio-Aliaga, I.
    Daniel, H.
    XENOBIOTICA, 2008, 38 (7-8) : 1022 - 1042
  • [44] Pharmacokinetics of Gefitinib: Roles of Drug Metabolizing Enzymes and Transporters
    Zhao, Can
    Han, Shu-Yan
    Li, Ping-Ping
    CURRENT DRUG DELIVERY, 2017, 14 (02) : 282 - 288
  • [45] Drug binding to blood proteins :: characteristics, roles and pathophysiological changes
    Tillement, Jean-Paul
    Duche, Jean-Claude
    Barre, Jerome
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (4-5): : 935 - 946
  • [46] Kinetic characterization of the transporters involved in the intestinal and hepatic processing of ezetimibe
    Kisser, B.
    Grytsyuk, O.
    Wildberg, C.
    Keiser, M.
    Siegmund, W.
    Oswald, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S16 - S16
  • [47] Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved
    Rui Li
    Hugh A. Barton
    Manthena V. Varma
    Clinical Pharmacokinetics, 2014, 53 : 659 - 678
  • [48] IN VITRO EFFECTS OF INTESTINAL AND HEPATIC UPTAKE TRANSPORTERS ON TALINOLOL UPTAKE
    Naddaf, F.
    Keiser, M.
    Didrigkeit, K.
    Oswald, S.
    Scheuch, E.
    Koeck, K.
    Kroemer, H. K.
    Siegmund, W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 : 23 - 23
  • [49] POTENTIAL IMPACT OF RENAL OR HEPATIC IMPAIRMENT ON DRUG TRANSPORTERS
    Lee, S.
    Chung, S.
    Volpe, D. A.
    Jappar, D.
    Fan, Y.
    Zhang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S85 - S86
  • [50] Dysregulation of Human Hepatic Drug Transporters by Proinflammatory Cytokines
    Hao, Tianran
    Tsang, Yik Pui
    Yin, Mengyue
    Mao, Qingcheng
    Unadkat, Jashvant D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 391 (01): : 82 - 90